Ghent University Academic Bibliography

Longitudinal analysis of a patient-reported outcome (ACTIVLIM) in Duchenne muscular dystrophy : a registry-based study

M. Cosyns, M. Jagut, N. De Meulemeester, J. Baets, D. Beysen, K. Claeys, N. Deconinck, Jan De Bleecker (UGent) , L. De Waele, N. Dubuisson, et al.

(2025) NEUROMUSCULAR DISORDERS. In Neuromuscular Disorders 53(Supplement S). p.19-20

Add to list

Overview of the Belgian neuromuscular diseases registry : more than a decade of data

M. Jagut, N. De Meulemeester, J. Baets, D. Beysen, V. Bissay, K. Claeys, A. Daron, Jan De Bleecker (UGent) , N. Deconinck, S. Delstanche, et al.

(2025) NEUROMUSCULAR DISORDERS. In Neuromuscular Disorders 53(Supplement S). p.135-135

Add to list

Long-term safety and efficacy of nipocalimab in generalized myasthenia gravis : vivacity-MG3 open-label extension phase results

K. Borst, C. Antozzi, T. Vu, S. Ramchandren, JR Nowak, C. Farmakidis, V. Bril, Jan De Bleecker (UGent) , H. Yang, E. Minks, et al.

(2025) NEUROMUSCULAR DISORDERS. In Neuromuscular Disorders 53(Supplement S). p.106-106

Add to list

Phenotypical and genotypical characterization of a cohort of 196 COL6-RD patients in Europe and Chile

M. Bisciglia, T. Stojkovic, C. Metay, V. Allamand, D. Natera-de Benito, A. Nascimento, K. Claeys, C. Castiglioni, B. Suarez, J. Vissing, et al.

(2025) NEUROMUSCULAR DISORDERS. In Neuromuscular Disorders 53(Supplement S). p.62-63

Add to list

Efficacy of SMA NBS : 4-year comparative study with control group

T. Dangouloff, L. De Waele, D. Beysen, N. Smeets, Arnaud Vanlander (UGent) , N. Benmhammed, C. Tychon, A. Daron, N. Deconinck, P. Dontaine, et al.

(2024) NEUROMUSCULAR DISORDERS. In Neuromuscular Disorders 43(Supplement 1). p.11-12

Add to list

272nd ENMC international workshop : 10 years of progress : revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands

James B Lilleker, Elie Naddaf, Christiaan G J Saris, Jens Schmidt, Marianne de Visser, Conrad C Weihl, Jan De Bleecker (UGent) and [missing] 272nd ENMC Workshop Participants

(2024) NEUROMUSCULAR DISORDERS. 37. p.36-51

Add to list

Large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and physical activity

P. 't Hoen, D. van As, Tine Claeys (UGent) , R. Salz, Ralf Gabriels (UGent) , Francis Impens (UGent) , Pieter-Jan Volders (UGent) , Lennart Martens (UGent) and B. van Engelen

(2023) NEUROMUSCULAR DISORDERS. In Neuromuscular Disorders 33(Supplement 1). p.S132-S133

Add to list

Journal Article
A1
open access

Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6-48 months with Duchenne muscular dystrophy amenable to exon 51 skipping

E. Mercuri, A. M. Seferian, L. Servais, N. Deconinck, H. Stevenson, X. Ni, W. Zhang, L. East, S. Yonren, F. Muntoni, et al.

(2023) NEUROMUSCULAR DISORDERS. 33(6). p.476-483

Add to list

Journal Article
A1
open access

Risk of malignant hyperthermia in patients carrying a variant in the skeletal muscle ryanodine receptor 1 gene

Lise Janssens, Joris De Puydt, Mauro Alessio Milazzo (UGent) , Sofie Symoens (UGent) , Jan De Bleecker (UGent) and Sarah Herdewyn (UGent)

(2022) NEUROMUSCULAR DISORDERS. 32(11-12). p.864-869

Add to list

239th ENMC International Workshop : Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018

Andrew L. Mammen, Yves Allenbach, Werner Stenzel, Olivier Benveniste, on behalf of the ENMC 239th Workshop Study Grp and Jan De Bleecker (UGent)

(2020) NEUROMUSCULAR DISORDERS. 30(1). p.70-92

Academic Bibliography

Longitudinal analysis of a patient-reported outcome (ACTIVLIM) in Duchenne muscular dystrophy : a registry-based study

Overview of the Belgian neuromuscular diseases registry : more than a decade of data

Long-term safety and efficacy of nipocalimab in generalized myasthenia gravis : vivacity-MG3 open-label extension phase results

Phenotypical and genotypical characterization of a cohort of 196 COL6-RD patients in Europe and Chile

Efficacy of SMA NBS : 4-year comparative study with control group

272nd ENMC international workshop : 10 years of progress : revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands

Large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and physical activity

Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6-48 months with Duchenne muscular dystrophy amenable to exon 51 skipping

Risk of malignant hyperthermia in patients carrying a variant in the skeletal muscle ryanodine receptor 1 gene

239th ENMC International Workshop : Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018

Contents

Support

Contact